Anixa Biosciences
ANIX • NASDAQ
Anixa Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Amit Kumar, with a market cap of $85.5M.
CEOAmit Kumar
Next Earnings
Upcoming earnings announcement for Anixa Biosciences
Date
Wednesday, May 27, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.09
Earnings History
Past 12 earnings reports for Anixa Biosciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Q1 2026 | -$0.08Est: -$0.09 | +11.1% | - | — |  10-Q |
| Feb 3, 2026 | Q4 2025 | —Est: -$0.10 | — | — | — | — |
| Sep 10, 2025 | Q3 2025 | -$0.07Est: -$0.10 | +30.0% | - | — | 10-Q |
| Mar 11, 2025 | Q1 2025 | -$0.10 | — | - | — | 10-Q |
| Jan 10, 2025 | Q4 2024 | -$0.09Est: -$0.11 | +18.2% | - | — | 10-K |
| Sep 6, 2024 | Q3 2024 | -$0.10Est: -$0.11 | +9.1% | - | — | 10-Q |
| Jun 4, 2024 | Q2 2024 | -$0.10Est: -$0.11 | +9.1% | - | — | 10-Q |
| Mar 12, 2024 | Q1 2024 | -$0.10Est: -$0.09 | -11.1% | - | — | 10-Q |
| Jan 16, 2024 | Q4 2023 | -$0.09Est: -$0.09 | 0.0% | - | — | 10-K |
| Sep 6, 2023 | Q3 2023 | -$0.08Est: -$0.09 | +11.1% | -Est: - | — | — |
| Jun 14, 2023 | Q2 2023 | -$0.07Est: -$0.11 | +36.4% | $210.0K | — | — |
| Mar 17, 2023 | Q1 2023 | -$0.08Est: -$0.11 | +27.3% | - | — | — |